U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024797) titled 'Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants' on June 09.
Brief Summary: This study will assess the adverse events, tolerability, and how oral doses of ABBV-932 moves through the body in healthy adult Chinese participants.
Study Start Date: Aug. 18
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-932
Oral Capsule
DRUG: Placebo for ABBV-932
Oral Capsule
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AbbVie
Published by HT Digital Content Services with permission from Health Daily Digest....